Wenfeng Cao

6PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 19, 2026
CAMK2D isoform 15 facilitates gefitinib resistance via AKT phosphorylation in lung adenocarcinoma.

|Feb 26, 2025
Clinicopathological characteristics and prognostic significance of HER2 status evaluation in patients with urothelial carcinoma: a retrospective single-center experience in China.

Manlin Yang, Ye Yao, Kun Wang

|Sep 18, 2023
Bioinformatic Analysis of The Prognostic Value of A Panel of Six Amino Acid Transporters in Human Cancers.

Yaqi Liu, Haijuan Xiong, Chenhui Yan

|May 22, 2023
ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma.

Tongyuan Qu, Wenshuai Zhang, Chenhui Yan

|Mar 12, 2021
A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma.

Qiujuan Huang, Tongyuan Qu, Lisha Qi

|Sep 12, 2020
Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China.

Qianru Guo, Ning Liu, Frank Wang

Pageof 1

Frequent Collaborators

1 joint publications

Wenjuan Ma

1 joint publications

Yaqi Liu

1 joint publications

Haijuan Xiong

1 joint publications

Chenhui Yan